- Home
- SSTK vs NAGE Comparison
SSTK vs NAGE Comparison
Compare SSTK & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSTK
- NAGE
- Stock Information
- Founded
- SSTK 2003
- NAGE 1999
- Country
- SSTK United States
- NAGE United States
- Employees
- SSTK N/A
- NAGE N/A
- Industry
- SSTK EDP Services
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- SSTK Technology
- NAGE Health Care
- Exchange
- SSTK Nasdaq
- NAGE Nasdaq
- Market Cap
- SSTK 724.0M
- NAGE 861.0M
- IPO Year
- SSTK 2012
- NAGE N/A
- Fundamental
- Price
- SSTK $20.87
- NAGE $9.63
- Analyst Decision
- SSTK Buy
- NAGE Strong Buy
- Analyst Count
- SSTK 4
- NAGE 3
- Target Price
- SSTK $43.67
- NAGE $17.00
- AVG Volume (30 Days)
- SSTK 196.0K
- NAGE 803.7K
- Earning Date
- SSTK 10-28-2025
- NAGE 10-30-2025
- Dividend Yield
- SSTK 6.24%
- NAGE N/A
- EPS Growth
- SSTK 38.48
- NAGE N/A
- EPS
- SSTK 1.81
- NAGE 0.22
- Revenue
- SSTK $1,010,504,000.00
- NAGE $116,303,000.00
- Revenue This Year
- SSTK $11.52
- NAGE $28.46
- Revenue Next Year
- SSTK $1.15
- NAGE $21.65
- P/E Ratio
- SSTK $11.66
- NAGE $44.84
- Revenue Growth
- SSTK 14.20
- NAGE 35.90
- 52 Week Low
- SSTK $14.35
- NAGE $3.16
- 52 Week High
- SSTK $38.80
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- SSTK 53.42
- NAGE 47.28
- Support Level
- SSTK $19.98
- NAGE $9.16
- Resistance Level
- SSTK $21.29
- NAGE $9.80
- Average True Range (ATR)
- SSTK 0.66
- NAGE 0.37
- MACD
- SSTK -0.06
- NAGE 0.02
- Stochastic Oscillator
- SSTK 54.22
- NAGE 49.60
About SSTK Shutterstock Inc.
Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.